Building on the fact that PD-L1 is a typical glycoprotein found on the cell membrane, we hypothesized that bisecting GlcNAc modification may regulate the killing function of CD8+ T cells by affecting the expression of PD-L1 in BC. The gene discussed is CD8A; the disease is breast cancer.